Pathway Bio
PrivateLast Round
Pre Seed
Oct 13, 2025
Total Funding Raised
$350,000
Company Overview
Pathway Bio is a healthtech company that provides a functional precision medicine platform to predict and validate cancer treatment outcomes using multiomic profiling, AI-driven prediction, and ex vivo microcancer technology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pathway Bio Comparables
Compare Pathway Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deep Origin | 81% | |
| AI Vivo | 77% | |
| Insilico Medicine | 76% |
Pathway Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 13, 2025 | ||||
| Accelerator | Jan 1, 2025 |
Pathway Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KQ Labs | Accelerator |
| LifeArc | Accelerator |
| Cancer Research Horizons | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
$50K raised from LifeArc, Cancer Research Horizons, and KQ Labs.
Pathway Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pathway Bio's valuation, stock price, and market status.
Is Pathway Bio a public or private company?
Pathway Bio is a private company.
What is the current stock price of Pathway Bio?
Pathway Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Pathway Bio worth (valuation)?
Valuation information for Pathway Bio is not publicly available.
Can I buy Pathway Bio stock?
Pathway Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pathway Bio's last funding round?
Pathway Bio's most recent funding round was Pre Seed on October 13, 2025.
Who are the main investors in Pathway Bio?
Key investors in Pathway Bio include KQ Labs, LifeArc, Cancer Research Horizons.
Will Pathway Bio IPO soon?
No public IPO plans have been announced for Pathway Bio.
How can I track Pathway Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pathway Bio's secondary market activity and sign up for updates.